{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:07:52Z","timestamp":1767053272610,"version":"3.48.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Eat Disord"],"DOI":"10.1186\/s40337-025-01409-5","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T23:16:59Z","timestamp":1767050219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring MDMA assisted therapy in eating disorders: mechanisms, clinical evidence, and future directions"],"prefix":"10.1186","volume":"13","author":[{"given":"Michael","family":"Harkhoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Offringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Vermetten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"5","key":"1409_CR1","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/ajcn\/nqy342","volume":"109","author":"G Marie","year":"2019","unstructured":"Marie G, D\u00e9chelotte P, Gr\u00e9gory L, Marie Pierre T. Prevalence of eating disorders over the 2000\u20132018 period: a systematic literature review. AM J Clin Nutr. 2019;109(5):1402\u201313. PMID 31051507.","journal-title":"AM J Clin Nutr"},{"key":"1409_CR2","doi-asserted-by":"crossref","unstructured":"Udo T, Grilo CM. Prevalence and correlates of DSM-5\u2013Defined eating disorders in a nationally representative sample of U.S. Adults. Biol Psychiatry. 2018;84(5):345\u201354.","DOI":"10.1016\/j.biopsych.2018.03.014"},{"issue":"1","key":"1409_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/00048670601057718","volume":"41","author":"F Fernandez-Aranda","year":"2007","unstructured":"Fernandez-Aranda F, Pinheiro AP, Tozzi F, Thornton LM, et al. Symptom profile of major depressive disorder in women with eating disorders. Aust N Z J Psychiatry. 2007;41(1):24\u201331. PMID 17464678.","journal-title":"Aust N Z J Psychiatry"},{"key":"1409_CR4","doi-asserted-by":"crossref","unstructured":"Blinder BJ, Cumella EJ, Sanathara VA. Psychiatric comorbidities of female inpatients with eating disorders. Psychosom Med. 2006;68(3):454\u201362.","DOI":"10.1097\/01.psy.0000221254.77675.f5"},{"key":"1409_CR5","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington D.C. 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"6","key":"1409_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/YCO.0000000000000545","volume":"32","author":"C Rijkers","year":"2019","unstructured":"Rijkers C, Schoorl M, van Hoeken D, Hoek HW. Eating disorders and posttraumatic stress disorders. Curr Opin Psychiatry. 2019;32(6):510\u20137. PMID 31313708.","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"1409_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/10640266.2014.857517","volume":"22","author":"S Tagay","year":"2014","unstructured":"Tagay S, Schlottbohm, Reyes-Rodriguez ML, Repic N, Senf W. Eating disorders, trauma, PTSD, and psychosocial resources. Eat Disord. 2014;22(1):33\u201349. PMID 24365526.","journal-title":"Eat Disord"},{"key":"1409_CR8","doi-asserted-by":"crossref","unstructured":"Brewerton TD. The integrated treatment of eating disorders, posttraumatic stress disorder, and psychiatric comorbidity: a commentary on the evolution of principles and guidelines. Front Psychiatry. 2023;14.","DOI":"10.3389\/fpsyt.2023.1149433"},{"key":"1409_CR9","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.19847.1","author":"E Attia","year":"2019","unstructured":"Attia E, Davis LE. Recent advances in therapies for eating disorders. F1000Res. 2019. https:\/\/doi.org\/10.12688\/f1000research.19847.1.","journal-title":"F1000Res"},{"key":"1409_CR10","doi-asserted-by":"crossref","unstructured":"Agras WS. Cognitive behavior therapy for the eating disorders. Psychiatr Clin North Am. 2019;42(2):169\u201379.","DOI":"10.1016\/j.psc.2019.01.001"},{"key":"1409_CR11","doi-asserted-by":"crossref","unstructured":"Milano W, Petrella C, Sabatino C, Capasso A. Treatment of bulimia nervosa with sertraline: a randomized controlled trial. Adv Ther. 2004;21(4): 232-7.","DOI":"10.1007\/BF02850155"},{"key":"1409_CR12","doi-asserted-by":"crossref","unstructured":"Milano W, Siano C, Petrella C, Capasso A. Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial. Adv Ther. 2005;22(3):278\u201383.","DOI":"10.1007\/BF02849936"},{"issue":"1","key":"1409_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00004714-199602000-00003","volume":"16","author":"MM Fitchter","year":"1996","unstructured":"Fitchter MM, Kr\u00fcger R, Rief W, Holland R, D\u00f6hne J. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology. J Clin Psychopharmacol. 1996;16(1):9\u201318. PMID 8834413.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"1409_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","volume":"176","author":"E Attia","year":"2019","unstructured":"Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, et al. Olanzapine versus placebo in adult outpatients with anorexia nervosa: A randomized clinical trial. Am J Psychiatry. 2019;176(6):449\u201356. PMID 30654643.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"1409_CR15","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1176\/appi.ajp.2008.07121900","volume":"165","author":"H Bissada","year":"2008","unstructured":"Bissada H, Tasca GA, Barber AM, Bradwejn J. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2008;165(10):1281\u20138. PMID 18558642.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1409_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/YIC.0b013e328080ca31","volume":"22","author":"F Brambilla","year":"2007","unstructured":"Brambilla F, Garcia CS, Fassino S, Daga GA, Santonastaso P, Favaro A, et al. Olanzapine therapy in anorexia nervosa: Psychobiological effects. Int Clin Psychopharmacol. 2007;22(4):197\u2013204. PMID 17519642.","journal-title":"Int Clin Psychopharmacol"},{"issue":"8","key":"1409_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/jclp.10065","volume":"58","author":"LH Jaycox","year":"2002","unstructured":"Jaycox LH, Zoellner L, Foa EB. Cognitive-behavior therapy for PTSD in rape survivors. J Clin Psychol. 2002;58(8):891\u2013906. PMID 12115713.","journal-title":"J Clin Psychol"},{"issue":"8","key":"1409_CR18","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1017\/S0033291723003446","volume":"54","author":"SL Wright","year":"2024","unstructured":"Wright SL, Karyotaki E, Cuijpers P, Bisson J, Papola D, Witteveen A, et al. EMDR v. other psychological therapies for PTSD: a systematic review and individual participant data meta-analysis. Psychol Med. 2024;54(8):1580\u20138. PMID: 38173121.","journal-title":"Psychol Med"},{"issue":"14","key":"1409_CR19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/jama.283.14.1837","volume":"283","author":"K Brady","year":"2000","unstructured":"Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, et al. Efficacy and safety of Sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283(14):1837\u201344. PMID 10770145.","journal-title":"JAMA"},{"issue":"9","key":"1409_CR20","first-page":"904","volume":"76","author":"J Merz","year":"2019","unstructured":"Merz J, Schwarzer G, Gerger H. Comparative efficacy and acceptability of pharmacological, psychotherapeutic, and combination treatments in adults with posttraumatic stress disorder: a network meta-analysis. JAMA. 2019;76(9):904\u201313. PMID 31188399.","journal-title":"JAMA"},{"issue":"12","key":"1409_CR21","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1017\/S003329171700349X","volume":"48","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Williams T, Nikolakopoulou A, Salanti G, Chaimani A, Ipser J, et al. Comparative efficacy and acceptability of Pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med. 2018;48(12):1975\u201384. PMID 29254516.","journal-title":"Psychol Med"},{"issue":"2","key":"1409_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.neuropharm.2011.06.012","volume":"62","author":"T Steckler","year":"2012","unstructured":"Steckler T, Risbrough V. Pharmacological treatment of PTSD \u2013 Established and new approaches. Neuropharmacology. 2012;62(2):617\u201327. PMID 21736888.","journal-title":"Neuropharmacology"},{"issue":"8","key":"1409_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1586\/ern.11.94","volume":"11","author":"CP McLean","year":"2011","unstructured":"McLean CP, Foa EB. Prolonged exposure therapy for post-traumatic stress disorder: a review of evidence and dissemination. Expert Rev Neurother. 2011;11(8):1151\u201363. PMID 21797656.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"1409_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/16506073.2018.1522371","volume":"48","author":"GJG Asmundson","year":"2019","unstructured":"Asmundson GJG, Thorisdottir AS, Roden-Foreman JW, Baird SO, Witcraft SM, Stein AT, et al. A meta-analytic review of cognitive processing therapy for adults with posttraumatic stress disorder. Cogn Behav Ther. 2019;48(1):1\u201314.","journal-title":"Cogn Behav Ther"},{"issue":"3","key":"1409_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0005-7916(89)90025-6","volume":"20","author":"F Shapiro","year":"1989","unstructured":"Shapiro F. Eye movement desensitization: a new treatment for post-traumatic stress disorder. J Behav Ther Exp Psychiatry. 1989;20(3):211\u20137.","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"2","key":"1409_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.2044-8260.1997.tb01408.x","volume":"36","author":"J Andrade","year":"1997","unstructured":"Andrade J, Kavanagh D, Baddeley A. Eye-movements and visual imagery: a working memory approach to the treatment of post-traumatic stress disorder. Br J Clin Psychol. 1997;36(2):209\u201323. PMID 9167862.","journal-title":"Br J Clin Psychol"},{"issue":"4","key":"1409_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jbtep.2011.03.004","volume":"42","author":"MA van den Hout","year":"2011","unstructured":"van den Hout MA, Engelhard IM, Beetsma D, Slofstra C, et al. EMDR and mindfulness. Eye movements and attentional breathing tax working memory and reduce vividness and emotionality of aversive ideation. J Behav Ther Exp Psychiatry. 2011;42(4):423\u201331. PMID 21570931.","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"1409_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.brat.2017.03.002","volume":"92","author":"A Leer","year":"2017","unstructured":"Leer A, Engelhard IM, Lenaert B, Struyf D, et al. Eye movement during recall reduces objective memory performance: an extended replication. Behav Res Ther. 2017;92:94\u2013105.","journal-title":"Behav Res Ther"},{"issue":"11","key":"1409_CR29","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1017\/S0033291706007963","volume":"36","author":"GH Seidler","year":"2006","unstructured":"Seidler GH, Wagner FE. Comparing the efficacy of EMDR and trauma-focused cognitive-behavioral therapy in the treatment of PTSD: a meta-analytic study. Psychol Med. 2006;36(11):1515\u201322. PMID 16740177.","journal-title":"Psychol Med"},{"issue":"3","key":"1409_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.biopsych.2006.03.040","volume":"61","author":"JI Hudson","year":"2006","unstructured":"Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National comorbidity survey replication. Biol Psychiatry. 2006;61(3):348\u201358. PMID 16815322.","journal-title":"Biol Psychiatry"},{"key":"1409_CR31","doi-asserted-by":"crossref","unstructured":"Mitchell KS, Scioli ER, Galovski T, Belfer PL, Cooper Z. Posttraumatic stress disorder and eating disorders: maintaining mechanisms and treatment targets. Eat Disord. 2021;29(3):292\u2013306.","DOI":"10.1080\/10640266.2020.1869369"},{"key":"1409_CR32","doi-asserted-by":"crossref","unstructured":"Scharff A, Ortiz SN, Forrest LN, Smith AR. Comparing the clinical presentation of eating disorder patients with and without trauma history and\/or comorbid PTSD. Eat Disord 2021; 29(1):88\u2013102.","DOI":"10.1080\/10640266.2019.1642035"},{"issue":"1","key":"1409_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40337-023-00773-4","volume":"11","author":"TD Brewerton","year":"2023","unstructured":"Brewerton TD, Gavidia I, Suro G, Perlman MM. Eating disorder patients with and without PTSD treated in residential care: discharge and 6-month follow-up results. J Eat Disord. 2023;11(1):48. PMID 26973828.","journal-title":"J Eat Disord"},{"issue":"1","key":"1409_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40337-022-00558-1","volume":"10","author":"MC Ten Napel-Schutz","year":"2022","unstructured":"Ten Napel-Schutz MC, Vroling M, Mares SHW, Arntz A. Treating PTSD with imagery rescripting in underweight eating disorder patients: a multiple baseline case series study. J Eat Disord. 2022;10(1):35. PMID 35264254.","journal-title":"J Eat Disord"},{"issue":"8","key":"1409_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11920-017-0806-6","volume":"19","author":"K Trottier","year":"2017","unstructured":"Trottier K, MacDonald DE. Update on psychological trauma, other severe adverse experiences and eating disorders: state of the research and future research directions. Curr Psychiatry Rep. 2017;19(8):45. PMID 28624866.","journal-title":"Curr Psychiatry Rep"},{"key":"1409_CR36","doi-asserted-by":"crossref","unstructured":"Purnell L, Chiu K, Bhutani GE, Grey N, El-Leithy S, Meiser-Stedman R. Clinicians\u2019 perspectives on retraumatisation during trauma-focused interventions for post-traumatic stress disorder: a survey of UK mental health professionals. J Anxiety Disord. 2024;106.","DOI":"10.1016\/j.janxdis.2024.102913"},{"issue":"2","key":"1409_CR37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/15248380231167399","volume":"25","author":"S Day","year":"2024","unstructured":"Day S, Hay P, Tannous WK, Fatt SJ, Mitchison D. A systematic review of the effect of PTSD and trauma on treatment outcomes for eating disorders. Trauma Violence Abuse. 2024;25(2):947\u201364. PMID 37125723.","journal-title":"Trauma Violence Abuse"},{"issue":"3","key":"1409_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1017\/S0033291721004967","volume":"52","author":"K Trottier","year":"2022","unstructured":"Trottier K, Monson CM, Wonderlich SA, Crosby RD. Results of the first randomized controlled trial of integrated cognitive-behavioral therapy for eating disorders and posttraumatic stress disorder. Psychol Med. 2022;52(3):587\u201396. PMID 34872625.","journal-title":"Psychol Med"},{"issue":"2","key":"1409_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/jts.22176","volume":"30","author":"K Trottier","year":"2017","unstructured":"Trottier K, Monson CM, Wonderlich SA, Olmsted MP. Initial findings from project recover: overcoming Co-Occurring eating disorders and posttraumatic stress disorder through integrated treatment. J Trauma Stress. 2017;30(2):173\u20137. PMID 28398626.","journal-title":"J Trauma Stress"},{"issue":"4","key":"1409_CR40","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/jclp.23106","volume":"77","author":"A Schardd","year":"2021","unstructured":"Schardd A, Ortiz SN, Forrest LN, Smith AR, Boswell JF. Post-traumatic stress disorder as a moderator of transdiagnostic, residential eating disorder treatment outcome trajectory. J Clin Psychol. 2021;77(4):986\u20131003. PMID 33449390.","journal-title":"J Clin Psychol"},{"key":"1409_CR41","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2147\/NDT.S199927","volume":"15","author":"A Grau","year":"2019","unstructured":"Grau A, Magall\u00f3n-Neri E, Faus G, Feixas G. Cognitive impairment in eating disorder patients of short and long-term duration: a case\u2013control study. Neuropsychiatr Dis Treat. 2019;15:1329\u201341. PMID 31190837.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"22","key":"1409_CR42","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.3390\/jcm11226683","volume":"11","author":"M Panero","year":"2022","unstructured":"Panero M, Longo P, De Bacco C, Abbate-Daga G, et al. Shame, guilt, and self-consciousness in anorexia nervosa. J Clin Med. 2022;11(22):6683. PMID 36421160.","journal-title":"J Clin Med"},{"issue":"9","key":"1409_CR43","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/eat.24248","volume":"57","author":"S Kenny","year":"2024","unstructured":"Kenny S, Erceg-Hurn D, Tonta KE, Raykos BC, et al. The contribution of shame to eating disorder treatment outcomes in a community mental health clinic. Int J Eat Disord. 2024;57(9):1936\u201344.","journal-title":"Int J Eat Disord"},{"issue":"12","key":"1409_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181\u201397.","journal-title":"J Psychopharmacol"},{"key":"1409_CR45","doi-asserted-by":"crossref","unstructured":"Davis AK, Barrett FS, May DG, Cosimano MP, et al. Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry 2021;78(5):1\u20139.","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"issue":"10","key":"1409_CR46","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","volume":"29","author":"JM Mitchell","year":"2023","unstructured":"Mitchell JM, Ot\u2019alora GM, van der Kolk B, Shannon S, et al. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nat Med. 2023;29(10):2473\u201380. PMID 37709999.","journal-title":"Nat Med"},{"issue":"15","key":"1409_CR47","first-page":"241378","volume":"12","author":"K Sung-Hyun","year":"2025","unstructured":"Sung-Hyun K, Sumin Y, Jeehye J, Heonghyeon C, et al. Psychedelic drugs in mental disorders: current clinical scope and deep Learning-Based advanced perspectives. Adv Sci (Weinh). 2025;12(15):241378. PMID 40112231.","journal-title":"Adv Sci (Weinh)"},{"key":"1409_CR48","doi-asserted-by":"crossref","unstructured":"Calder A, Mock S, Friedli N, Pasi P, Hasler G. Psychedelics in the treatment of eating disorders: rationale and potential mechanisms. Eur Neuropsychopharmacol 2023;75:1\u201314.","DOI":"10.1016\/j.euroneuro.2023.05.008"},{"key":"1409_CR49","volume":"46","author":"E Koning","year":"2024","unstructured":"Koning E, Brietzke E. Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials. Trends Psychiatry Psychother. 2024;46:e20220597.","journal-title":"Trends Psychiatry Psychother"},{"issue":"6","key":"1409_CR50","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","volume":"27","author":"JM Mitchell","year":"2021","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27(6):1025\u201333.","journal-title":"Nat Med"},{"key":"1409_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fpsyt.2019.00138","volume":"10","author":"B Sessa","year":"2019","unstructured":"Sessa B, Higbed L, Nutt D. A review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted psychotherapy. Front Psychiatry. 2019;10:138. PMID 30949077.","journal-title":"Front Psychiatry"},{"key":"1409_CR52","doi-asserted-by":"crossref","unstructured":"Vida T, Sottile RJ. A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy. Front Psychiatry. 2022;13.","DOI":"10.3389\/fpsyt.2022.991753"},{"key":"1409_CR53","doi-asserted-by":"publisher","first-page":"110367","DOI":"10.1016\/j.mehy.2020.110367","volume":"146","author":"TD Brewerton","year":"2021","unstructured":"Brewerton TD, Lafrance A, Mithoefer MC. The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD. Med Hypotheses. 2021;146:110367. PMID 33203569.","journal-title":"Med Hypotheses"},{"issue":"1","key":"1409_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08174-x","volume":"25","author":"C Bhagavan","year":"2024","unstructured":"Bhagavan C, Glue P, Evans W, Reynolds L, Turner T, King C, et al. Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomized controlled trial. Trials. 2024;25(1):336.","journal-title":"Trials"},{"issue":"4","key":"1409_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/17470910802649470","volume":"4","author":"GJH Dumon","year":"2009","unstructured":"Dumon GJH, Sweep FCGJ, van der Steen R, Hermsen R, Donders ART, Touw DJ, et al. Increased Oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci. 2009;4(4):359\u201366. PMID 19562632.","journal-title":"Soc Neurosci"},{"issue":"4","key":"1409_CR56","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","volume":"189","author":"CD Verrico","year":"2007","unstructured":"Verrico CD, Miller GM, Madras BK. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology. 2007;189(4):489\u2013503. PMID 16220332.","journal-title":"Psychopharmacology"},{"issue":"4","key":"1409_CR57","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00204-020-02693-7","volume":"94","author":"D Luethi","year":"2020","unstructured":"Luethi D, Liechti ME. Designer drugs: mechanism of action and adverse effects. Arch Toxicol. 2020;94(4):1085\u2013133. PMID 32249347.","journal-title":"Arch Toxicol"},{"key":"1409_CR58","unstructured":"Holley A, Simonson B, Kivell BM. MDMA regulates serotonin transporter function via a protein kinase C dependent mechanism. J Addict Prev. 2013;1."},{"issue":"2","key":"1409_CR59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00213-012-2645-9","volume":"222","author":"CM Hysek","year":"2012","unstructured":"Hysek CM, Domes G, Liechti ME. MDMA enhances Mind reading of positive emotions and impairs Mind reading of negative emotions. Psychopharmacology. 2012;222(2):293\u2013302. PMID 22277989.","journal-title":"Psychopharmacology"},{"key":"1409_CR60","doi-asserted-by":"crossref","unstructured":"Matsushita H, Nishiki T. Human social behavior and oxytocin: molecular and neuronal mechanisms. 2025;570:48\u201354.","DOI":"10.1016\/j.neuroscience.2025.02.026"},{"key":"1409_CR61","doi-asserted-by":"crossref","unstructured":"Shahrestani S, Kemp AH, Guastella AJ. The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis. Neuropsypharmacology. 2013;38(10):1929-36.","DOI":"10.1038\/npp.2013.86"},{"issue":"7466","key":"1409_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature12518","volume":"501","author":"G D\u00f6len","year":"2013","unstructured":"D\u00f6len G, Darvishzadeh, Huang KW, Malenka RC. Social reward requires coordinated activity of nucleus accumbens Oxytocin and serotonin. Nature. 2013;501(7466):179\u201384. PMID 24025838.","journal-title":"Nature"},{"issue":"7754","key":"1409_CR63","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41586-019-1075-9","volume":"569","author":"R Nardou","year":"2019","unstructured":"Nardou R, Lewis EM, Rothhaas R, Xu R, et al. Oxytocin-dependent reopening of a social reward learning critical period with MDMA. Nature. 2019;569(7754):116\u201320. PMID 30944474.","journal-title":"Nature"},{"issue":"17","key":"1409_CR64","doi-asserted-by":"publisher","first-page":"eadl6665","DOI":"10.1126\/sciadv.adl6554","volume":"10","author":"B Rein","year":"2024","unstructured":"Rein B, Raymond K, Boustani C, Tuy S, et al. MDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus accumbens. Sci Adv. 2024;10(17):eadl6665. PMID 38657057.","journal-title":"Sci Adv"},{"issue":"7966","key":"1409_CR65","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","volume":"618","author":"R Nardou","year":"2023","unstructured":"Nardou R, Sawyer E, Song YJ, Wilkinson M, Padovan-Hernandez Y, de Deus JL, et al. Psychedelics reopen the social reward learning critical period. Nature. 2023;618(7966):790\u20138. PMID 37316665.","journal-title":"Nature"},{"key":"1409_CR66","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-3-319-94593-4_2","volume":"21","author":"R Marek","year":"2018","unstructured":"Marek R, Sah P. Neural circuits mediating fear learning and extinction. Adv Neurobiol. 2018;21:35\u201348. PMID 30334218.","journal-title":"Adv Neurobiol"},{"key":"1409_CR67","doi-asserted-by":"crossref","unstructured":"Harnett NG, Goodman AM, Knight DC. PTSD-related neuroimaging abnormalities in brain function, structure, and biochemistry. Exp Neurol. 2020.","DOI":"10.1016\/j.expneurol.2020.113331"},{"key":"1409_CR68","doi-asserted-by":"publisher","first-page":"175653","DOI":"10.1016\/j.ejphar.2023.175653","volume":"946","author":"H Esaki","year":"2023","unstructured":"Esaki H, Sasaki Y, Nishitani N, Kamada H, et al. Role of 5-HT1A receptors in the basolateral amygdala on 3,4-methylenedioxymethamphetamine-induced prosocial effects in mice. Eur J Pharmacol. 2023;946:175653. PMID 36907260.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1409_CR69","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/ewjm.173.2.129","volume":"173","author":"PA Kelly","year":"2000","unstructured":"Kelly PA. Does recreational ecstasy use cause long-term cognitive problems? West J Med. 2000;173(2):129\u201330. PMID 10924441.","journal-title":"West J Med"},{"key":"1409_CR70","doi-asserted-by":"crossref","unstructured":"Farrar AM, Nordstrom IH, Shelley K, Archer G, Kunstman KN, Palamar JJ. Ecstasy, molly, MDMA: what health practitioners need to know about this common recreational drug. Dis Mon. 2025;71(3).","DOI":"10.1016\/j.disamonth.2024.101851"},{"issue":"3","key":"1409_CR71","first-page":"192","volume":"1","author":"ME Liechti","year":"2014","unstructured":"Liechti ME. Effects of MDMA on body temperature in humans. Temp (Austin). 2014;1(3):192\u2013200. PMID 27626046.","journal-title":"Temp (Austin)"},{"issue":"8","key":"1409_CR72","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/hup.351","volume":"16","author":"AC Parrot","year":"2001","unstructured":"Parrot AC. Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol. 2001;16(8):557\u201377. PMID 12404536.","journal-title":"Hum Psychopharmacol"},{"key":"1409_CR73","doi-asserted-by":"crossref","unstructured":"Parrott AC. Recreational Ecstasy\/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav. 2002;71(4):837\u201344.","DOI":"10.1016\/S0091-3057(01)00711-0"},{"key":"1409_CR74","doi-asserted-by":"publisher","first-page":"113894","DOI":"10.1016\/j.expneurol.2021.113894","volume":"347","author":"G Costa","year":"2022","unstructured":"Costa G, Golembiowska K. Neurotoxicity of MDMA: main effects and mechanisms. Exp Neurol. 2022;347:113894. PMID 34655576.","journal-title":"Exp Neurol"},{"issue":"3","key":"1409_CR75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1515\/ijamh-2013-0052","volume":"25","author":"Y Dobry","year":"2013","unstructured":"Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013;25(3):193\u20139. PMID 24006318.","journal-title":"Int J Adolesc Med Health"},{"issue":"1","key":"1409_CR76","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.300.1.236","volume":"300","author":"C Hernandez-Lopez","year":"2022","unstructured":"Hernandez-Lopez C, Farr\u00e9 M, Roset PN, Menoyo E, et al. 3,4-Methylenedioxymethamphetamine (Ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther. 2022;300(1):236\u201344. PMID 11752122.","journal-title":"J Pharmacol Exp Ther"},{"key":"1409_CR77","doi-asserted-by":"crossref","unstructured":"Daza-Losada M, Rodr\u00edguez-Arias M, Maldonado C, Aguilar MA, et al. Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice. Neurotoxicol Teratol 2009;31(1):49\u201359.","DOI":"10.1016\/j.ntt.2008.07.005"},{"key":"1409_CR78","doi-asserted-by":"crossref","unstructured":"Makunts T, Jerome L, Abagyan R, de Boer A. Reported cases of serotonin syndrome in MDMA users in FAERS database. Front Psychiatry. 2022;12:824288.","DOI":"10.3389\/fpsyt.2021.824288"},{"key":"1409_CR79","doi-asserted-by":"crossref","unstructured":"Feduccia AA, Jerome L, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R. Breakthrough for trauma treatment: safety and efficacy of MDMA-Assisted psychotherapy compared to Paroxetine and Sertraline. Front Psychiatry. 2019;10.","DOI":"10.3389\/fpsyt.2019.00650"},{"issue":"4","key":"1409_CR80","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1037\/pst0000172","volume":"55","author":"C Fl\u00fcckiger","year":"2018","unstructured":"Fl\u00fcckiger C, Del Re AC, Wampold BE, Horvath A. The alliance in adult psychotherapy: A meta-analytic synthesis. Psychother (Chic). 2018;55(4):316\u201340.","journal-title":"Psychother (Chic)"},{"key":"1409_CR81","doi-asserted-by":"crossref","unstructured":"Wang JB, Lin J, Bedrosian L, Coker A, Jerome I, Feduccia A, et al. Scaling up: multisite open-label clinical trials of MDMA-assisted therapy for severe posttraumatic stress disorder. J Humanist Psychol. 2021.","DOI":"10.1177\/00221678211023663"},{"issue":"3","key":"1409_CR82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/02791072.2008.10400637","volume":"40","author":"J Carlos Bouso","year":"2008","unstructured":"Carlos Bouso J, Doblin R, Farr\u00e9 M, Angel Alc\u00e1zar M, et al. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. J Psychoact Drugs. 2008;40(3):225\u201336. PMID 19004414.","journal-title":"J Psychoact Drugs"},{"issue":"5","key":"1409_CR83","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/0269881117691569","volume":"31","author":"P Vizeli","year":"2017","unstructured":"Vizeli P, Liechti ME. Safety pharmacology of acute MDMA administration in healthy subjects. J Psychopharmacol. 2017;31(5):576\u201388 (PMID 28443695).","journal-title":"J Psychopharmacol"},{"issue":"2","key":"1409_CR84","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","volume":"26","author":"R de la Torre","year":"2004","unstructured":"de la Torre R, Farr\u00e9 M, Roset Pere N, Pizarro N, et al. Human Pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit. 2004;26(2):137\u201344. PMID 15228154.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"1409_CR85","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40519-018-0567-1","volume":"24","author":"S Giovinazzo","year":"2019","unstructured":"Giovinazzo S, Sukkar SG, Rosa GM, Zappi A, et al. Anorexia nervosa and heart disease: a systematic review. Eat Weight Disord. 2019;24(2):199\u2013207. PMID 30173377.","journal-title":"Eat Weight Disord"},{"key":"1409_CR86","doi-asserted-by":"crossref","unstructured":"Lakier Smith L. The central role of hypothermia and hyperactivity in anorexia nervosa: a hypothesis. Front Behav Neurosci. 2021;15:700645.","DOI":"10.3389\/fnbeh.2021.700645"},{"key":"1409_CR87","unstructured":"The Multidisciplinary Association for Psychedelic Studies. Treatment manual: mdma-assisted therapy for PTSD. https:\/\/maps.org\/mdma\/mdma-resources\/treatment-manual-mdma-assisted-psychotherapy-for-ptsd\/. Accessed 3 May 2025."},{"key":"1409_CR88","doi-asserted-by":"crossref","unstructured":"Thompson CJ, Martin-Wagar CA. Cognitive flexibility and emotion regulation in eating disorder patients with comorbid generalized anxiety and posttraumatic stress symptoms. Res Sq. 2024; rs.3.rs-436208.","DOI":"10.21203\/rs.3.rs-4326208\/v1"},{"key":"1409_CR89","doi-asserted-by":"crossref","unstructured":"Zeifman RJ, Kettner H, Ross S, Weiss B, Mithoefer MC, Mithoefer AT, et al. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder. Eur J Psychotraumatol. 2024;15(1).","DOI":"10.1080\/20008066.2023.2297536"},{"key":"1409_CR90","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-244X-9-67","volume":"9","author":"S Fassino","year":"2009","unstructured":"Fassino S, Piero A, Tomba E, Abbate-Daga G. Factors associated with dropout from treatment for eating disorders: a comprehensive literature review. BMC Psychiatry. 2009;9:67. PMID 19818137.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"1409_CR91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000289028","volume":"65","author":"DN Clinton","year":"1996","unstructured":"Clinton DN. Why do eating disorder patients drop out?? Psychother Psychosom. 1996;65(1):29\u201335. PMID 8838694.","journal-title":"Psychother Psychosom"},{"key":"1409_CR92","doi-asserted-by":"crossref","unstructured":"Lewis C, Roberts NP, Gibson S, Bisson JI. Dropout from psychological therapies for post-traumatic stress disorder (PTSD) in adults: systematic review and meta-analysis. Eur J Psychotraumatol. 2020;11(1).","DOI":"10.1080\/20008198.2019.1709709"},{"issue":"11","key":"1409_CR93","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23(11):3170\u201382. PMID 29898390.","journal-title":"Cell Rep"},{"key":"1409_CR94","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s10020-024-01013-4","volume":"30","author":"RV Lima da Cruz","year":"2024","unstructured":"Lima da Cruz RV, Leao RN, Moulin TC. Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review. Mol Med. 2024;30:244. PMID 39701927.","journal-title":"Mol Med"},{"issue":"1","key":"1409_CR95","doi-asserted-by":"publisher","first-page":"2485513","DOI":"10.1080\/20008066.2025.2485513","volume":"16","author":"G Agin-Liebes","year":"2025","unstructured":"Agin-Liebes G, Zeifman RJ, Mitchell JM. Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder. Eur J Psychotraumatol. 2025;16(1):2485513. PMID 40331914.","journal-title":"Eur J Psychotraumatol"},{"issue":"1","key":"1409_CR96","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00103-015-2259-6","volume":"25","author":"A Maercker","year":"2016","unstructured":"Maercker A, Hecker T. [Consequences of trauma and violence: impact on psychological well-being]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016;25(1):28\u201334. PMID 26459566.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"4","key":"1409_CR97","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40653-019-00275-z","volume":"13","author":"T Groth","year":"2019","unstructured":"Groth T, Hilsenroth M, Boccio D, Gold J. Relationship between trauma history and eating disorders in adolescents. J Child Adolesc Trauma. 2019;13(4):443\u201353. PMID 33269044.","journal-title":"J Child Adolesc Trauma"},{"issue":"8","key":"1409_CR98","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1017\/S0033291716003561","volume":"47","author":"ML Molendijk","year":"2017","unstructured":"Molendijk ML, Hoek HW, Brewerton TD, Elzinga BM. Childhood maltreatment and eating disorder pathology: a systematic review and dose-response meta-analysis. Psychol Med. 2017;47(8):1402\u201316. PMID 28100288.","journal-title":"Psychol Med"},{"key":"1409_CR99","doi-asserted-by":"crossref","unstructured":"Brewerton TD, Wang JB, Lafrance A, Pamplin C, et al. MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD. J Psychiatr Res 2022;148:128\u201335.","DOI":"10.1016\/j.jpsychires.2022.03.008"},{"issue":"1","key":"1409_CR100","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40337-025-01245-7","volume":"13","author":"L Vuillier","year":"2025","unstructured":"Vuillier L, Wang Z, Hassan S, Haarison A, et al. Emotional overload in bulimia nervosa: an ERP study of emotion processing and regulation. J Eat Disord. 2025;13(1):74. PMID 40312378.","journal-title":"J Eat Disord"},{"key":"1409_CR101","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cpr.2015.05.010","volume":"40","author":"M Lavender Jason","year":"2015","unstructured":"Lavender Jason M, Wonderlich SA, Engel SG, Gordon KH, et al. Dimensions of emotion dysregulation in bulimia nervosa. Clin Psychol Rev. 2015;40:111\u201322. PMID 26112760.","journal-title":"Clin Psychol Rev"},{"issue":"5","key":"1409_CR102","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1017\/S1092852920001674","volume":"26","author":"RG Boswell","year":"2021","unstructured":"Boswell RG, Grilo CM. General impulsivity in Binge-Eating disorder. CNS Sepctr. 2021;26(5):538\u201344. PMID 32690126.","journal-title":"CNS Sepctr"},{"issue":"8","key":"1409_CR103","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cpr.2008.09.001","volume":"28","author":"S Fisher","year":"2008","unstructured":"Fisher S, Smith GT, Cyders MA. Another look at impulsivity: A meta-analytic review comparing specific dispositions to rash action in their relationship to bulimic symptoms. Clin Psychol Rev. 2008;28(8):1413\u201325. PMID 18848741.","journal-title":"Clin Psychol Rev"},{"issue":"5","key":"1409_CR104","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/eat.20730","volume":"43","author":"JE Wildes","year":"2010","unstructured":"Wildes JE, Ringham RM, Marcus MD. Emotion avoidance in patients with anorexia nervosa: initial test of a functional model. Int J Eat Disord. 2010;43(5):398\u2013404. PMID 19670226.","journal-title":"Int J Eat Disord"},{"key":"1409_CR105","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3389\/fpsyg.2017.02273","volume":"8","author":"EC Gregertsen","year":"2017","unstructured":"Gregertsen EC, Mandy W, Serpell L. The egosyntonic nature of anorexia: an impediment to recovery in anorexia nervosa treatment. Front Psychol. 2017;8:2273. PMID 29312100.","journal-title":"Front Psychol"},{"key":"1409_CR106","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-244X-14-62","volume":"14","author":"G Abbate-Daga","year":"2014","unstructured":"Abbate-Daga G, Amianto F, Delsedime N, De-Bacco C, et al. Resistance to treatment and change in anorexia nervosa: a clinical overview. BMC Psychiatry. 2014;14:62. PMC 3975843.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"1409_CR107","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.amjmed.2015.06.031","volume":"129","author":"P Westmoreland","year":"2016","unstructured":"Westmoreland P, Krantz MJ, Mehler PS. Medical complications of anorexia nervosa and bulimia. Am J Med. 2016;129(1):30\u20137. PMID 26169883.","journal-title":"Am J Med"},{"key":"1409_CR108","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40337-020-00298-0","volume":"8","author":"KA Christensen","year":"2020","unstructured":"Christensen KA, Haynos AF. A theoretical review of interpersonal emotion regulation in eating disorders: enhancing knowledge by bridging interpersonal and affective dysfunction. J Eat Disord. 2020;8:21. PMID 32514350.","journal-title":"J Eat Disord"},{"issue":"11","key":"1409_CR109","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/scan\/nst161","volume":"9","author":"CM Hysek","year":"2013","unstructured":"Hysek CM, Schmid Y, Simmler LD, Domes G, et al. MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci. 2013;9(11):1645\u201352. PMID 24097374.","journal-title":"Soc Cogn Affect Neurosci"},{"issue":"7","key":"1409_CR110","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/npp.2014.12","volume":"39","author":"MG Kirkpatrick","year":"2014","unstructured":"Kirkpatrick MG, Lee R, Wardle MC, Jacob S, et al. Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacology. 2014;39(7):1654\u201363 (PMID 24448644).","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"1409_CR111","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0005-7967(02)00088-8","volume":"41","author":"CG Fairburn","year":"2003","unstructured":"Fairburn CG, Cooper Z, Shafran R. Cognitive behaviour therapy for eating disorders: a transdiagnostic theory and treatment. Behav Res Ther. 2003;41(5):509\u201328. PMID 12711261.","journal-title":"Behav Res Ther"},{"issue":"8","key":"1409_CR112","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/eat.22867","volume":"51","author":"DC Walker","year":"2018","unstructured":"Walker DC, White EK, Srinivasan VJ. A meta-analysis of the relationships between body checking, body image avoidance, body image dissatisfaction, mood, and disordered eating. Int J Eat Disord. 2018;51(8):745\u201370. PMID 29659039.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"1409_CR113","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/erv.2249","volume":"22","author":"JF Morgan","year":"2014","unstructured":"Morgan JF, Lazarova S, Schelhase M, Saeidi S. Ten session body image therapy: efficacy of a manualized body image therapy. Eur Eat Disord Rev. 2014;22(1):66\u201371. PMID 24006359.","journal-title":"Eur Eat Disord Rev"},{"issue":"3","key":"1409_CR114","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3233\/NRE-230270","volume":"55","author":"W Dunn","year":"2024","unstructured":"Dunn W, Bershad A, Krantz DE, Vermetten E. MDMA for treatment of PTSD and neurorehabilitation in military populations. NeuroRehabilitation. 2024;55(3):357\u201368. PMID 39331116.","journal-title":"NeuroRehabilitation"},{"issue":"7","key":"1409_CR115","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/archgenpsychiatry.2011.74","volume":"68","author":"J Arcelus","year":"2011","unstructured":"Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011;68(7):724\u201331.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"1409_CR116","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.eatbeh.2014.04.003","volume":"15","author":"JJ Aardoom","year":"2014","unstructured":"Aardoom JJ, Dingemans AE, Boogaard LH, van Furth EF. Internet and patient empowerment in individuals with symptoms of an eating disorder: a cross-sectional investigation of a pro-recovery focused e-community. Eat Behav. 2014;15(3):350\u20136. PMID 25064280.","journal-title":"Eat Behav"},{"issue":"3","key":"1409_CR117","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/1363459315574118","volume":"20","author":"BH Walters","year":"2016","unstructured":"Walters BH, Adams S, Broer T, Bal R. Proud2Bme: exploratory research on care and control in young women\u2019s online eating disorder narratives. Health (London). 2016;20(3):220\u201341. PMID 25769694.","journal-title":"Health (London)"},{"key":"1409_CR118","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-45378-6_15","volume-title":"Medical complications of eating disorders, substance use disorders, and addictions","author":"PS Powers","year":"2014","unstructured":"Powers PS, Cloak NL. Medical complications of eating disorders, substance use disorders, and addictions. Berlin, Heidelberg: Springer; 2014."},{"key":"1409_CR119","doi-asserted-by":"crossref","unstructured":"Mehler PS, Brown C. Anorexia nervosa - medical complications. J Eat Disord 2015;3:11.","DOI":"10.1186\/s40337-015-0040-8"},{"key":"1409_CR120","doi-asserted-by":"crossref","unstructured":"Novella A, Elli C, Pasina L. Selective serotonin reuptake inhibitors and risk of serotonin syndrome as consequence of drug-drug interactions: analysis of the FDA adverse event reporting system. Med Princ Pract. 2025;1\u20138.","DOI":"10.1159\/000546109"},{"key":"1409_CR121","doi-asserted-by":"crossref","unstructured":"Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95(4):434\u201341.","DOI":"10.1093\/bja\/aei210"}],"container-title":["Journal of Eating Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-025-01409-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40337-025-01409-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-025-01409-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:03:37Z","timestamp":1767053017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40337-025-01409-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1186\/s40337-025-01409-5","relation":{},"ISSN":["2050-2974"],"issn-type":[{"type":"electronic","value":"2050-2974"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}